标题
Novel prime-boost vaccine strategies against HIV-1
作者
关键词
-
出版物
Expert Review of Vaccines
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2019-07-05
DOI
10.1080/14760584.2019.1640117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Natural Products and HIV/AIDS
- (2018) Daniele C. Cary et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial
- (2018) Edna Omar Viegas et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Immune Correlate-Guided HIV Vaccine Design
- (2018) Galit Alter et al. Cell Host & Microbe
- Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
- (2018) Dan H Barouch et al. LANCET
- Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
- (2018) Siriwat Akapirat et al. PLoS One
- Advances in HIV-1 Vaccine Development
- (2018) Yong Gao et al. Viruses-Basel
- Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study
- (2018) Simon de Montigny et al. Scientific Reports
- Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection
- (2018) Sarah Auclair et al. PLoS Pathogens
- A step forward for HIV vaccines
- (2018) Dan H Barouch Lancet HIV
- Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
- (2018) Linda-Gail Bekker et al. Lancet HIV
- Modulation of Vaccine-induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans
- (2018) Franco Pissani et al. JOURNAL OF VIROLOGY
- Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial
- (2018) Marnie L. Elizaga et al. PLoS One
- Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
- (2018) Joris Hemelaar et al. LANCET INFECTIOUS DISEASES
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1
- (2018) Kathryn E. Stephenson et al. PLoS One
- Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design
- (2018) Edna O. Viegas et al. PLoS One
- The expanding array of HIV broadly neutralizing antibodies
- (2018) Laura E. McCoy Retrovirology
- Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
- (2017) Lynette Siv Chea et al. Expert Review of Vaccines
- Complex immune correlates of protection in HIV-1 vaccine efficacy trials
- (2017) Georgia D. Tomaras et al. IMMUNOLOGICAL REVIEWS
- An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic
- (2017) Anthony S. Fauci JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost
- (2017) Julie A Ake et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial
- (2017) Supachai Rerks-Ngarm et al. JOURNAL OF INFECTIOUS DISEASES
- V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144
- (2017) Lautaro G. Perez et al. PLoS One
- Progress in HIV vaccine development
- (2017) Denise C. Hsu et al. Human Vaccines & Immunotherapeutics
- Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial
- (2017) David Easterhoff et al. PLoS Pathogens
- Novel Concepts for HIV Vaccine Vector Design
- (2017) Quazim A. Alayo et al. mSphere
- New concepts in HIV-1 vaccine development
- (2016) Kathryn E Stephenson et al. CURRENT OPINION IN IMMUNOLOGY
- Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects
- (2016) Yunda Huang et al. JOURNAL OF IMMUNOLOGY
- First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
- (2016) Julien Nyombayire et al. JOURNAL OF INFECTIOUS DISEASES
- Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
- (2016) B M Gunn et al. Mucosal Immunology
- Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
- (2016) Monica Vaccari et al. NATURE MEDICINE
- Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries
- (2016) Thomas M. Harmon et al. PLoS One
- Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
- (2016) Michelle C. Crank et al. PLoS One
- Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
- (2016) Kimia Kardani et al. VACCINE
- Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer
- (2016) Colin Havenar-Daughton et al. Cell Reports
- Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions
- (2016) Janet M. McNicholl Human Vaccines & Immunotherapeutics
- Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
- (2016) Matthew Zirui Tay et al. PLoS Pathogens
- Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
- (2016) Agricola Joachim et al. PLoS One
- HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials
- (2015) Nittaya Phanuphak et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
- (2015) Jerome H. Kim et al. Annual Review of Medicine
- Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083
- (2015) Stephen R. Walsh et al. JOURNAL OF INFECTIOUS DISEASES
- Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
- (2015) Juan García-Arriaza et al. JOURNAL OF VIROLOGY
- COMPASS identifies T-cell subsets correlated with clinical outcomes
- (2015) Lin Lin et al. NATURE BIOTECHNOLOGY
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
- (2015) Gloria Omosa-Manyonyi et al. PLoS One
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
- (2015) Juliet Mpendo et al. PLoS One
- Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
- (2015) Timothy R. Fouts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Immune correlates of vaccine protection against HIV-1 acquisition
- (2015) Lawrence Corey et al. Science Translational Medicine
- HIV specific responses induced in nonhuman primates with ANRS HIV-Lipo-5 vaccine combined with rMVA-HIV prime or boost immunizations
- (2015) Nathalie Dereuddre-Bosquet et al. VACCINE
- Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21
- (2015) Zoltan Beck et al. VACCINE
- Prospects for a globally effective HIV-1 vaccine
- (2015) Jean-Louis Excler et al. VACCINE
- Letter to the Editor on: The RV144 vaccine regimen was not associated with enhancement of infection
- (2015) Sandhya Vasan et al. Human Vaccines & Immunotherapeutics
- Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models
- (2015) Dobromir Dimitrov et al. EBioMedicine
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
- (2015) Patricia. J. Munseri et al. PLoS One
- HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults
- (2014) Glenda E. Gray et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1-Uninfected Adult Participants
- (2014) Sharon E. Frey et al. Clinical and Vaccine Immunology
- Characterization of T-Cell Responses to Conserved Regions of the HIV-1 Proteome in BALB/c Mice
- (2014) Beatrice Ondondo et al. Clinical and Vaccine Immunology
- Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
- (2014) Jean-Louis Excler et al. Clinical and Vaccine Immunology
- HIV Vaccine Efficacy and Immune Correlates of Risk
- (2014) Robert O'Connell et al. CURRENT HIV RESEARCH
- Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load
- (2014) Yves Lévy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial
- (2014) Pierre-Alexandre Bart et al. JOURNAL OF CLINICAL INVESTIGATION
- Toll-Like Receptor 7/8 (TLR7/8) and TLR9 Agonists Cooperate To Enhance HIV-1 Envelope Antibody Responses in Rhesus Macaques
- (2014) M. A. Moody et al. JOURNAL OF VIROLOGY
- Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)
- (2014) Mary E. Enama et al. PLoS One
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
- (2014) Surender Khurana et al. PLoS One
- Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals
- (2014) Haitao Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune Activation with HIV Vaccines
- (2014) A. S. Fauci et al. SCIENCE
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- HIV-1 vaccines
- (2014) Jean-Louis Excler et al. Human Vaccines & Immunotherapeutics
- Enhancing poxvirus vectors vaccine immunogenicity
- (2014) Juan García-Arriaza et al. Human Vaccines & Immunotherapeutics
- Pre-existing immunity against Ad vectors
- (2014) Hugues Fausther-Bovendo et al. Human Vaccines & Immunotherapeutics
- Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
- (2014) Susan Zolla-Pazner et al. EBioMedicine
- Broad and Potent Cellular and Humoral Immune Responses After a Second Late HIV-Modified Vaccinia Virus Ankara Vaccination in HIV-DNA-Primed and HIV-Modified Vaccinia Virus Ankara-Boosted Swedish Vaccinees
- (2013) Charlotta Nilsson et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees
- (2013) P. Liu et al. JOURNAL OF VIROLOGY
- Harnessing CD4+ T cell responses in HIV vaccine development
- (2013) Hendrik Streeck et al. NATURE MEDICINE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
- (2013) Susan Zolla-Pazner et al. PLoS One
- Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- (2013) Raphael Gottardo et al. PLoS One
- Differential Binding of IgG and IgA to Mucus of the Female Reproductive Tract
- (2013) Kelly M. Fahrbach et al. PLoS One
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of replication-competent viral vectors for HIV vaccine delivery
- (2013) Christopher L. Parks et al. Current Opinion in HIV and AIDS
- Novel directions in HIV-1 vaccines revealed from clinical trials
- (2013) Jean-Louis Excler et al. Current Opinion in HIV and AIDS
- Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
- (2012) D. C. Montefiori et al. JOURNAL OF INFECTIOUS DISEASES
- Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Acquired HIV-1 Infection in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX B/E
- (2012) Supachai Rerks-Ngarm et al. JOURNAL OF INFECTIOUS DISEASES
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens
- (2012) Silvia Ratto-Kim et al. PLoS One
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
- (2011) Nicole Frahm et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
- (2011) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
- (2011) Gavin J. Churchyard et al. PLoS One
- AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?
- (2010) Jean-Louis Excler et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Replicating viral vectors as HIV vaccines: Summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference
- (2010) J.L. Excler et al. BIOLOGICALS
- Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
- (2010) Robert M Paris et al. Expert Review of Vaccines
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Heterologous prime–boost vaccination
- (2009) Shan Lu CURRENT OPINION IN IMMUNOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started